Tasectan and Xilaplus in the new German GPGN Guidelines
Z Gastroenterol 2024; 62(09): 1574-1643 Getting into treatment guidelines is lengthy, especially for new products that need time to gather sufficient scientific and real-life evidence.
New publication on good results with EHO-85 hydrogel compared to products commonly used in wound healing.
Olive tree (Olea europaea) leaf extract (OELE) has important antioxidant and anti-inflammatory properties, supporting its use in human clinical practice (1). A clinical trial and
Publication on the antioxidant and wound-healing properties of EHO-85
The excess of free radicals in the wound environment contributes to its stagnation during the inflammatory phase, favouring hard-to-heal wounds. Oxidative stress negatively affects cells
Partner Devicare, S.L.
We would like to announce our new partnership with Devicare, S.L., to bring Utipro Plus AF into the Spanish market! We’re excited about this new
New publication on hydrogel EHO-85 in anal fissures
Last July 2024, information from the Journal of Wound Management, the official journal of the European Society of Wound Management (EWMA), was published on Linkedin.
New Publication on hydrogel EHO-85 in difficult-to-heal wounds
Chronic wounds, especially those that are hard-to-heal, constitute a serious public-health problem. To evaluate the superiority of a hydrogel (EHO-85), containing Olea europaea leaf extract
Tasectan MDR Approved
GREAT NEWS! Noventure is delighted to announce that our medical device Tasectan has just been granted a new CЄ Certificate under MDR Regulation. With 3,7
UTIPRO® PLUS AF reaches Central Asia
We are happy to inform that Utipro® Plus AF is ready to land in Central Asia thanks to its very recent registration in Kazakhstan. All
New publication for UTIPRO® PLUS / UTIPRO® PLUS AF (The UTISWISS Study)
We are happy to announce the publication of new evidence on the benefit of an antibiotic-free approach (xyloglucan, hibiscus and propolis for oral administration) in
